NASDAQ: MEHAFunctional Brands Inc Stock
$0.22+0.01 (+4.76%)
Updated Feb 11, 2026
MEHA Price
$0.22
Fair Value Price
N/A
Market Cap
$3.53M
52 Week Low
$0.18
52 Week High
$8.00
P/E
-4.32x
P/B
5.83x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$6.80M
Earnings
-$377.56k
Gross Margin
56%
Operating Margin
1.3%
Profit Margin
-5.6%
Debt to Equity
12.62
Operating Cash Flow
$2M
Beta
5.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MEHA Overview
The company manufactures and distributes nutraceutical supplements in the U.S., covering categories such as pain, energy, prenatal, general health, bone & joint, gastro, immunity, cardiac, detox, brain & memory, sleep, and urinary. It also offers hemp-derived products including capsules, gummies and tinctures.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MEHA's potential to beat the market
- MEHA doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Food
Industry Rating
C
MEHA
RankedUnranked of 49
RankedUnranked of 49
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $26.14 | A | |
| $78.99 | B | |
| $122.73 | B |
Be the first to know about important MEHA news, forecast changes, insider trades & much more!
MEHA News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MEHA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MEHA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MEHA is poor value based on its book value relative to its share price (5.83x), compared to the US Packaged Foods industry average (1.65x)
P/B vs Industry Valuation
MEHA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more MEHA due diligence checks available for Premium users.
Valuation
MEHA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-4.32x
Industry
10.98x
Market
44.56x
MEHA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.83x
Industry
1.65x
MEHA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MEHA's financial health
Profit margin
Revenue
$1.7M
Net Income
$259.0k
Profit Margin
15.3%
MEHA's Earnings (EBIT) of $88.67k... subscribe to Premium to read more.
Interest Coverage Financials
MEHA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.2M
Liabilities
$7.6M
Debt to equity
12.62
MEHA's short-term liabilities ($5.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MEHA's short-term assets ($4.21M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MEHA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$830.6k
Investing
-$8.5k
Financing
-$74.4k
MEHA's operating cash flow ($1.54M)... subscribe to Premium to read more.
Debt Coverage Financials
MEHA vs Food Stocks
Functional Brands Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.